AlphAIalphai — Financial news for AI agents
SEC EDGARSEP 31 min read$ETSY

Silverman Josh sold $1.1M of ETSY

Silverman Josh sold 13,367 shares of ETSY INC (ETSY) at an average of $82.11 ($81.33–$84.00, $1.10M total) across 3 trades over 2026-09-01 to 2026-09-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Silverman Josh
Published Sep 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 7:12 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ETSY
Bearish
medium confidence
Mentioned
$ETSY
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ETSYBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, useful for short‑term trading decisions.

02

Market read

Insider sales are closely monitored; this filing adds new information for ETSY traders.

03

What to watch

Potential upcoming product launches or earnings could offset the negative sentiment from the sale.

Relevance 5/10Novelty 7/10Timing: filed today

Background

SEC Form 4 filings disclose insider transactions; a 10b5-1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$ETSYBearishMedium confidence
Context

Director Josh Silverman sold $1.1M of ETSY shares via a 10b5-1 plan, reducing his stake to 249,559 shares.

Expected impact

Modest downside pressure; possible 1‑2% dip if market interprets as negative.

Evidence & confidence

Director-level insider sales are watched by traders; the $1.1M amount is material for ETSY but not large enough to trigger a major move.

Market effects

Sector

Minimal impact on the broader e‑commerce sector; only ETSY is directly affected.

Regional

No significant regional effect; the filing is U.S.-focused.

Global

Limited global relevance; only investors tracking ETSY may react.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move under a pre‑arranged plan, not a bearish signal.

Key entities

  • Director
    Josh Silverman

    ETS Y director executing a pre‑arranged sale of shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ETSY insider trading history →

Related articles

AUG 20
$WMTMed

Retailers Report AI-Driven Sales, Bigger Baskets in Q2 Earnings

Walmart, Amazon, and Target reported Q2 earnings showing AI-driven sales growth. Walmart's eCommerce grew 23%, with AI assistant users spending 40% more. Amazon's Alexa for Shopping saw active users nearly double. Target's digital traffic from AI platforms grew over 3.5x faster than the industry average. Albertsons saw a 10-26% increase in order value with AI tools. Shopify's AI-referred traffic and orders tripled, but AI's impact on discovery-driven retail remains uncertain.

pymnts.com3 min
AUG 20
$ETSYHigh

Bank of America Resets Etsy Stock Price Target After Event

Bank of America upgraded Etsy to Buy, raising its price target to $105 from $88, citing structural growth. The bank expects mid-single-digit gross merchandise sales growth, higher profitability, and increased shareholder returns. Etsy's new management team is seen as key to reinvigorating growth. BofA raised its fiscal 2027 estimates for gross merchandise sales, EBITDA, and EPS.

tradingview.com2 min
AUG 20
$DEMed

Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges

Deere shares rose 5.1% after reporting stronger-than-expected Q3 results, with EPS of $5.10 and net sales of $11B. CrowdStrike fell 2.8% following its CTO's departure. Advance Auto Parts dropped 15.9% due to lower normalized earnings. Etsy gained 3.9% after a BofA upgrade. Ultragenyx surged 11.1% on FDA approval for a gene therapy. Moderna fell 13% after a prior surge. Wolfspeed plunged 10.5% on wider-than-expected Q4 loss. Webull rose 13.8% on strong Q2 results.

investing.com3 min